Surgalign Holdings Inc
F:RT2
Surgalign Holdings Inc
Other Equity
Surgalign Holdings Inc
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Surgalign Holdings Inc
F:RT2
|
Other Equity
-$3.3m
|
CAGR 3-Years
25%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-3%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Other Equity
-$34.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Other Equity
-$28.2m
|
CAGR 3-Years
49%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Other Equity
$65.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Other Equity
-$1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Other Equity
-$3.7m
|
CAGR 3-Years
39%
|
CAGR 5-Years
17%
|
CAGR 10-Years
3%
|
|
Surgalign Holdings Inc
Glance View
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.
See Also
What is Surgalign Holdings Inc's Other Equity?
Other Equity
-3.3m
USD
Based on the financial report for Mar 31, 2023, Surgalign Holdings Inc's Other Equity amounts to -3.3m USD.
What is Surgalign Holdings Inc's Other Equity growth rate?
Other Equity CAGR 10Y
-3%
Over the last year, the Other Equity growth was -74%. The average annual Other Equity growth rates for Surgalign Holdings Inc have been 25% over the past three years , 11% over the past five years , and -3% over the past ten years .
